Skip to main content

Table 5 Five-year disease-specific survival according to tumour location, 2006–2015 (95% CIa)

From: Long-term survival among colorectal cancer patients in Finland, 1991–2015: a nationwide population-based registry study

 

All tumour sites

Right-sided colon

Left-sided colon

Rectum

FCR classificationb

  FCR 0

62.3 (60.5–64.1)

66.0 (62.9–69.1)

63.5 (59.8–67.2)

59.3 (56.8–61.8)

  FCR 1

89.9 (88.9–90.9)

89.5 (87.7–91.3)

91.2 (89.4–93.0)

89.5 (88.1–90.9)

  FCR 2

65.3 (63.5–67.1)

59.6 (56.5–62.7)

67.7 (64.2–71.2)

68.4 (65.7–71.1)

  FCR 3

43.9 (42.5–45.3)

46.2 (43.8–48.6)

41.4 (38.7–44.1)

43.3 (40.9–45.7)

  FCR 4

49.4 (46.3–52.5)

45.3 (40.6–50.0)

49.4 (42.5–56.3)

53.5 (48.4–58.6)

  FCR 5

81.5 (79.9–83.1)

84.6 (82.1–87.1)

82.2 (79.5–84.9)

78.2 (75.6–80.9)

  FCR 6

14.1 (12.3–15.9)

9.5 (7.0–12.0)

15.5 (12.2–18.8)

16.9 (14.0–19.8)

  All patients

61.1 (60.5–61.7)

59.9 (58.7–61.1)

61.0 (59.6–62.4)

62.3 (61.3–63.3)

  1. Abbreviations: aConfidence interval. bFinnish Cancer Registry. 0) Unknown, 1) localised, 2) nonlocalised with only regional lymph node metastases, 3) metastasised further than to regional lymph nodes or invasion to adjacent tissues, 4) nonlocalised with no information on extent, 5) locally advanced with the tumour invading adjacent tissues and 6) nonlocalised with distant lymph node metastases as well